Status:
COMPLETED
tDCS and Cognitive Efficiency in Ageing
Lead Sponsor:
University of Valencia
Conditions:
Aging
Mild Cognitive Impairment
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Normal aging is associated with a progressive decline in cognitive functions, especially memory. This decline in cognitive function can negatively impact the quality of life of older adults. Although ...
Detailed Description
The clinical trial protocol involves the recruitment of participants from three different groups: healthy older adults, individuals with mild cognitive impairment (MCI), and patients with Alzheimer's ...
Eligibility Criteria
Inclusion
- For the group of healthy older adults:
- MEC score greater than 26 points.
- GDS between 1 and 3.
- For the MCI group:
- MEC score between 21 and 26 points.
- GDS between 1 and 3.
- For the mild EA group:
- MEC score between 18 and 23 points.
- GDS between 3 and 4.
Exclusion
- Presentation of contraindications to tDCS (presence of intracranial metal implants, intracranial hypertension, comitial risk).
- Significant asymptomatic neurovascular disease
- History of previous symptomatic stroke
- Alcohol or drug abuse/dependence
- Severe psychiatric symptoms
- Depressive symptoms higher than mild
Key Trial Info
Start Date :
July 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2023
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05216315
Start Date
July 30 2020
End Date
May 30 2023
Last Update
December 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Psychology
Valencia, Spain, 46010